Sanofi 'confident' of vaccine by early 2021

Sanofi 'confident' of vaccine by early 2021Подробнее

Covid vaccine will be available by the end of 2021: Sanofi CEOПодробнее

Sanofi eyes approval of COVID-19 vaccine by first half of 2021Подробнее

Sanofi: Our vaccine could serve as an excellent booster shotПодробнее

Sanofi halts development of its Covid mRNA vaccineПодробнее

Sanofi, GSK say Covid-19 vaccine won't be ready until late 2021Подробнее

Covid vaccine by Sanofi-GSK delayed after disappointing results in older patientsПодробнее

Sanofi expecting for approval on Covid-19 vaccine in the beginning of 2021, also European markets upПодробнее

U.S. Likely to Get Sanofi's Covid-19 Vaccine First If It SucceedsПодробнее

Sanofi's first quarter boosted by eczema treatment and vaccinesПодробнее

Glaxo Joins Forces With Sanofi to Develop Coronavirus VaccineПодробнее

Jim Cramer on Sanofi & GSK partnership on coronavirus vaccineПодробнее

Sanofi CEO Paul Hudson on COVID-19 and potential vaccine (Full Stream 11/10)Подробнее

Covid-19 Vaccine: Building Confidence and Access | SWITCH 2020Подробнее

No Covid-19 vaccine expected ‘until 2021’, virologist says amid Sanofi rowПодробнее

Sanofi Has Two Covid Vaccines in Clinical TrialsПодробнее

Sanofi drops vaccine bid amid rivals' successПодробнее

Sanofi sees vaccine trial completed in first quarterПодробнее

Sanofi and GSK see positive interim results for their Covid vaccine in trialsПодробнее

Sanofi CFO details earnings, COVID-19 vaccine outlook, and drug developmentПодробнее